Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur
Ajouter le résultat dans votre panier Faire une suggestion Affiner la rechercheRapport
B. KILMER ; J. P. CAULKINS ; R. L. PACULA ; R. J. MACCOUN ; P. H. REUTER | Santa Monica, CA : Rand Corporation | Occasional Papers | 2010To learn more about the possible outcomes of marijuana legalization in California, RAND researchers constructed a model based on a series of estimates of current consumption, current and future prices, how responsive use is to price changes, tax[...]Livre
Article : Périodique
In recent years a number of studies have attempted to rank drugs by a single measure of harmfulness as the basis for decisions about scheduling and classification. These efforts are fundamentally flawed, both conceptually and methodologically. T[...]Rapport
B. KILMER ; J. P. CAULKINS ; G. MIDGETTE ; L. DAHLKEMPER ; R. J. MACCOUN ; R. L. PACULA | Santa Monica, CA : Rand Corporation | Research Reports | 2013In 2012, Washington state voters passed Initiative 502 (I-502), which removed the prohibition on the production, distribution, and possession of marijuana for nonmedical purposes and required the state to regulate and tax a new marijuana industr[...]Article : Périodique
Having a sense of the scale of an illicit drug market is important for projecting consequences of alternative policy regimes. In this article, we review two general approaches to drug market estimation - supply-side and demand-side - before turn[...]Article : Périodique
Aims: Drug policy strategies and discussions often use prevalence of drug use as a primary performance indicator. However, three other indicators are at least as relevant: the number of heavy users, total expenditures and total amount consumed. [...]Périodique
J. H. JAFFE ; M. GOSSOP ; M. TYNDALL ; R. E. MANN ; P. REUTER ; W. HAO ; D. WEATHERBURN ; J. P. CAULKINS ; L. DEGENHARDT ; W. HALL ; C. DAY ; P. DIETZE ; L. COLLINS ; POINTER S. | 2005Neuf commentaires sont proposés. Le premier, au regard des résultats de cette étude analyse un événement similaire survenu aux Etats-Unis en 1972/1973. Le deuxième s'intéresse aux conséquences du transfert de l'usage injectable d'héroïne vers l'[...]Rapport
B. KILMER ; J. TAYLOR ; J. P. CAULKINS ; P. A. MUELLER ; A. J. OBER ; B. PARDO ; R. SMART ; L. STRANG ; P. H. REUTER | Santa Monica, CA : Rand Corporation | Research Reports | 2018Current levels of opioid-related morbidity and mortality in the United States are staggering. Data for 2017 indicate that there were more than 47,000 opioid-involved overdose deaths, and one in eight adults now reports having had a family member[...]Article : Périodique
Background and Aims: In 2014 the legislature of Vermont, USA passed a law requiring the Secretary of Administration to report on the consequences of legalizing marijuana. The RAND Corporation was commissioned to write that report. This paper sum[...]Rapport
J. P. CAULKINS ; B. KILMER ; M. A. R. KLEIMAN ; R. J. MACCOUN ; G. MIDGETTE ; P. OGLESBY ; R. L. PACULA ; P. REUTER | Santa Monica, CA : Rand Corporation | Research Reports | 2015Marijuana legalization is a controversial and multifaceted issue that is now the subject of serious debate. Since 2012, four U.S. states have passed ballot initiatives to remove prohibition and legalize a for-profit commercial marijuana industry[...]Article : Périodique
Aims No modern jurisdiction has ever legalized commercial production, distribution and possession of cannabis for recreational purposes. This paper presents insights about the effect of legalization on production costs and consumption and highli[...]Article : Périodique
Until November 2012, no modern jurisdiction had removed the prohibition on the commercial production, distribution, and sale of marijuana for nonmedical purposes - not even the Netherlands. Government agencies in Colorado and Washington are now [...]Périodique
P. REUTER ; J. P. CAULKINS | 2003Une étude de Cunningham & Liu (Addiction 2003 Sep;98(9):1229-37) montre que les trois réglementations sur les précurseurs des méthamphétamines (1989, 1995 et 1997) ont eu pour bénéfice de diminuer les admissions hospitalières dans 3 Etats de l'O[...]Article : Périodique
H. A. POLLACK, Auteur ; P. REUTER, Auteur ; J. P. CAULKINS, Auteur du commentaire ; D. MEJIA, Auteur du commentaire ; V. FELBAB-BROWN, Auteur du commentaire |Aims: To review empirical research that seeks to relate marginal increases in enforcement against the supply of illicit drugs to changes in drug prices at the level of the drug supply system being targeted. Method: Review of empirical studies.[...]Livre
T. F. BABOR ; J. P. CAULKINS ; G. EDWARDS ; B. FISCHER ; D. R. FOXCROFT ; K. HUMPHREYS ; I. S. OBOT ; J. REHM ; P. REUTER ; R. ROOM ; I. ROSSOW ; J. STRANG | Oxford - New York : Oxford University Press | 2010Drug use represents a significant burden to public health through disease, disability and social problems, and policy makers are becoming increasingly interested in how to develop evidence-based drug policy. It is therefore crucial to strengthen[...]
